
The slide to be stained for ER
comprised the following five tissues:
|
No. |
Tissue |
ER-positivity* |
ER-intensity* |
|
1. |
Uterine cervix
|
80-90 % |
Moderate to strong |
|
2. |
Breast ductal carcinoma |
Negative |
Negative |
|
3. |
Breast ductal carcinoma |
Negative |
Negative |
|
4. |
Breast ductal carcinoma |
60-80 % |
Weak to moderate |
|
5. |
Breast ductal carcinoma |
90-100 % |
Strong |
*ER-status and staining pattern as
characterized by NordiQC reference laboratories using the mAb clone
6F11 and the rmAb clone SP1.
All tissues were fixed in 10% neutral buffered
formalin for 24 – 48 hours and processed according to the “Consensus
recommendations on estrogen receptor testing in breast cancer by
immunohistochemistry”, AIMM, vol 16, no. 6, 2008.
Criteria for assessing an ER staining as optimal included:
-
A moderate to strong, distinct nuclear staining of both the columnar
and squamous epithelial cells and most of the stromal cells (with
the exception of endothelial cells and lymphoid cells) in the
uterine cervix.
-
An at least weak to moderate distinct nuclear staining of the
appropriate proportion of the neoplastic cells in the breast ductal
carcinoma no. 4.
-
A strong distinct nuclear staining of the appropriate proportion of
the neoplastic cells in the breast ductal carcinoma no. 5.
-
No nuclear staining in the neoplastic cells in the breast carcinoma
no. 2 and 3 and no more than a weak cytoplasmic reaction in cells
with a strong nuclear staining.
A cytoplasmic reaction in the breast ductal carcinoma no. 2 was
accepted when using the mAb clone 1D5, as this did not influence the
interpretation.
144 laboratories participated in this assessment. 74 % achieved a
sufficient mark. In table 1 the antibodies (Abs) used and marks are
summarized.
Table 1.
Abs and
assessment marks
for ER, run B8
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
|
rmAb clone SP1 |
35
2
1
1 |
NeoMarkers
Dako
Diagnostic Biosystems
Zhongshan Bio |
14 |
13 |
8 |
4 |
69 % |
71 % |
|
mAb clone 6F11 |
22
2
2
1 |
Novocastra
Monosan
Vector
Biocare |
14 |
7 |
4 |
2 |
78 % |
84 % |
|
mAb clone 1D5 |
20
4 |
Dako
Immunologic |
4 |
9 |
4 |
7 |
54 % |
76 % |
|
mAb
clones 1D5+6F11 |
2 |
NeoMarkers |
0 |
1 |
1 |
0 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
|
rmAb clone SP1,
790-4324/25 |
40 |
Ventana |
33 |
5 |
1 |
1 |
95 % |
97 % |
|
rmAb clone SP1,
IR151 |
7 |
Dako |
1 |
3 |
2 |
1 |
57 % |
67 % |
|
mAb clone 1D5,
IS654 |
1 |
Dako |
1 |
0 |
0 |
0 |
- |
- |
|
mAb clones 1D5
+ ER-2-123, K4071/SK310 |
2 |
Dako |
0 |
1 |
0 |
1 |
- |
- |
|
mAb clone 6F11
+ rmAb clone SP1, IP308 |
1 |
BioCare |
0 |
1 |
0 |
0 |
- |
- |
|
mAb clone 6F11,
PA0151 |
1 |
Novocastra |
0 |
0 |
0 |
1 |
- |
- |
|
Total |
144 |
|
67 |
40 |
20 |
17 |
107 |
- |
|
Proportion |
|
|
46 % |
28 % |
14 % |
12 % |
74 % |
- |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Abs
rmAb SP1: The protocols giving an optimal result were all based on
heat induced epitope retrieval (HIER) using Tris-EDTA/EGTA pH 9
(2/12)*, Target Retrieval Solution (TRS) pH 9 (EnVision FLEX TRS
high pH, Dako, (4/10), Cell Conditioning 1 (BenchMark, Ventana)
(3/4), Bond Epitope Retrieval Solution 2 (Bond, Leica) (1/2), EDTA/EGTA pH 8 (1/1)* or Citrate pH 6 (3/7) as retrieval buffer.
The rmAb was typically diluted in the range of 1:25– 1:250 depending
on the total sensitivity of the protocol employed. Using these
protocol settings 25 out of 35 (71 %) laboratories produced a
sufficient staining (optimal or good).
* (number of optimal results/number of laboratories using this
buffer)
mAb 6F11: the protocols giving an optimal result were all based on
HIER using Tris-EDTA/EGTA pH 9 (4/8), TRS pH 9 (EnVision FLEX TRS
high pH, Dako, (4/6), Bond Epitope Retrieval Solution 2 (Bond,
Leica) (3/6), Cell Conditioning 1 (BenchMark, Ventana) (1/4) or
Citrate pH 6 (2/3) as retrieval buffer. The mAb was typically
diluted in the range of 1:30– 1:400 depending on the total
sensitivity of the protocol employed. Using these protocol settings
21 out of 25 (84 %) laboratories produced a sufficient staining
(optimal or good).
mAb 1D5: the protocols giving an optimal result were all based on
HIER using Tris-EDTA/EGTA pH 9 (1/12) or TRS pH 9 (EnVision FLEX
TRS high pH, Dako, (3/8) as retrieval buffer. The mAb was typically
diluted in the range of 1:50– 1:200 depending on the total
sensitivity of the protocol employed. Using these protocol settings
13 out of 17 (76 %) laboratories produced a sufficient staining
(optimal or good).
Ready-To-Use Abs
rmAb clone SP1, prod. no 790-4324/25, Ventana: The protocols giving
an optimal result were all based on HIER on the BenchMark XT or the
Ultra using Cell Conditioning 1, mild or standard, an incubation
time of 16-32 min in the primary Ab and iView or ultraView as the
detection system. 1 laboratory used the Ab with HIER in Citrate pH
6, UltraView + amplification using the Nexes. Using these protocol
settings 38 out of 39 (97 %) laboratories produced a
sufficient staining.
rmAb clone SP1, prod. no IR151, Dako: The protocol giving an optimal
result was based on HIER using TRS pH 9 (EnVision FLEX TRS high pH)
for 20 min in the PT-Link, an incubation time of 20 min in the
primary Ab and EnVision Flex (K8000) as the detection system. Using
these protocol settings 4 out of 6 (67 %) laboratories produced a
sufficient staining.
mAb clone 1D5, prod. no IS654, Dako: The protocol giving an optimal
result was based on HIER using TRS pH 9 (EnVision FLEX TRS high pH)
for 20 min in the PT-Link, an incubation time of 20 min in the
primary Ab and EnVision Flex (K8000) as the detection system.
The most frequent causes of insufficient stainings were:
- Too low concentration of the primary antibody.
- Insufficient HIER (use of citrate pH 6.0 and/or too short
efficient heating time)
- Excessive retrieval impairing the morphology
In this assessment the prevalent feature of an insufficient staining
was a general too weak reaction or complete false negative reaction
especially in the ductal carcinoma no. 4 with 60-80% positivity.
This pattern was seen in 89 % (33 out of 37) of the insufficient
results. As found in the previous runs the uterine cervix could be
used as an appropriate control and critical stain quality indicator
for the ER staining. In the optimal protocols almost all the
epithelial cells throughout the layers of the squamous epithelium
and in the glands showed a moderate to strong and distinct nuclear
reaction compared to the protocols giving insufficient results in
which both the proportion of positive cells and the intensity was
significantly reduced. In this run, all the 3 most widely used Abs
for ER, the mAb clones 1D5 and 6F11 and the rmAb clone SP1 could be
used to obtain an optimal staining. An optimal staining could both
be obtained, when the Abs were used as a concentrate and applied in
an in-house protocol or applied as a Ready-To-Use format.
In table 2 the overall performance and accumulated pass rates of the
three most widely used markers for ER in the NordiQC assessments are
listed.
As observed in the previous assessment of ER an insufficient staining
could also be due to excessive HIER typically as a consequence of
too long heating time and/or too high temperature hampering the
morphology and thus complicating the interpretation. This pattern
was seen in 11 % of the insufficient results.
Table 2. Results for the three most used Abs in eight ER tests in
NordiQC
|
|
All ER
assessments*
All protocol settings |
All ER
assessments*
Optimal protocol settings** |
|
|
Protocols |
Sufficient |
Optimal |
Protocols |
Sufficient |
Optimal |
|
mAb clone 1D5 |
244 |
150 (62 %) |
44 (18 %) |
127 |
91 (72 %) |
44 (35 %) |
|
mAb 6F11 |
240 |
182 (76 %) |
94 (39 %) |
190 |
164 (86 %) |
101 (53 %) |
|
rmAb SP1 |
247 |
210 (85 %) |
151 (61 %) |
231 |
208 (90 %) |
151 (65 %) |
*Runs 8, 10, 13, B1, B3, B5, B7, B8. ** HIER settings and dilution
range of the Ab in all assessments giving an optimal result.
This was the 8' assessment of ER in the NordiQC breast module and a
relative constant proportion of sufficient results have been
obtained in the previous 6 runs as shown in table 3, despite
many new participants:
Table 3:
Sufficient over-all results for ER in the eight NordiQC runs
Conclusion
The mAb clone 6F11 and the rmAb SP1 seem to be the most robust Abs
for ER. HIER is mandatory, preferable in an alkaline buffer and
shall be performed to provide an optimal balance between sensitivity
and preserved morphology. The concentration of the Ab must be
carefully calibrated on an appropriate control such as the uterine
cervix in which both the epithelial cells and most stromal cells
shall show a strong distinct nuclear reaction with minimal
cytoplasmic reaction. |